IDO1 and metabolic dysfunction-associated steatohepatitis: While increased IDO1 expression, in the great majority of cases, has been implicated in atheroprotection [8,9,10,11,12,13,14,15,16], its role in liver inflammation and NAFLD/NASH is less clear.